SCHEMBL4501236

SCHEMBL4501236

CCCCCCCCCCCCOC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.41
CA1 P00915 8/20 0.39
CA2 P00918 8/20 0.39
CA9 Q16790 7/20 0.39
LPAR3 Q9UBY5 6/20 0.39
LPAR2 Q9HBW0 5/20 0.39
CA12 O43570 3/20 0.39
CA7 P43166 3/20 0.39
CA14 Q9ULX7 3/20 0.39
LPAR1 Q92633 2/20 0.39
CA3 P07451 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CA5A P35218 2/20 0.39
CA5B Q9Y2D0 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276634 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL16311961 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL16311962 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL16311963 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL4505591 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL2647917 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL24829886 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL278721 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL4493956 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A
SCHEMBL127022 1.00 THRB (0.44) THRBTSHRMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370985-B2 Multicomponent diesel composition NESTE OYJ (FI) 2022-06-28 US claimed
US-11319500-B2 Multicomponent diesel composition NESTE OYJ (FI) 2022-05-03 US claimed
US-20210292669-A1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2021-09-23 US claimed
CN-110099986-B Multi-component diesel fuel composition 耐思特公司 2021-07-09 CN claimed
CN-110088249-B Multi-component diesel fuel composition 耐思特公司 2021-06-25 CN claimed
EP-3555241-B1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2020-11-11 EP claimed
EP-3555240-B1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2020-10-14 EP claimed
EP-3555240-A1 A MULTICOMPONENT DIESEL COMPOSITION Neste Oyj (FI) 2019-10-23 EP claimed
EP-3555241-A1 A MULTICOMPONENT DIESEL COMPOSITION Neste Oyj (FI) 2019-10-23 EP claimed
CN-110099986-A Multicomponent Dresel fuel compositions 奈斯特化学公司 2019-08-06 CN claimed
CN-110088249-A Multicomponent Dresel fuel compositions 奈斯特化学公司 2019-08-02 CN claimed
WO-2018115575-A1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2018-06-28 WO claimed
WO-2018115574-A1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2018-06-28 WO claimed
EP-4277591-A1 ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR Momentive Performance Materials GmbH (DE) 2023-11-22 EP disclosed
CN-116670108-A Ether compounds as volatiles for treating amino acid based substrates such as skin and hair 迈图高新材料有限责任公司 2023-08-29 CN disclosed
WO-2022152742-A1 ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2022-07-21 WO disclosed
US-20090318513-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN RECEPTOR AGONISM SHIONOGI & CO., LTD. 2009-12-24 US disclosed
US-7601746-B2 Compounds exhibiting thrombopoietin receptor agonism SHIONOGI & CO., LTD. (JP) 2009-10-13 US disclosed
US-20070043087-A1 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid EDDINGPHARM (HONG KONG) COMPANY LIMITED (CN) 2007-02-22 US disclosed
EP-1655291-A1 COMPOUNDS HAVING THROMBOPOIETIN RECEPTOR AGONISM SHIONOGI & CO., LTD. (JP) 2006-05-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318513-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN RECEPTOR AGONISM MPL, TEK, GHRHR THRB 92/4885TSHR 9/4885MEN1 534/4885
US-20070043087-A1 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid DHFR, NAT1, ACR THRB 2080/4885TSHR 757/4885MEN1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.